High-dose melphalan chemotherapy with autologous stem cell transplant in 63 patients with AL amyloidosis:: Experiences in a centre

被引：0
|
作者：
Schoenland, S.
Hegenbart, U.
Dengler, J.
Bochtler, T.
Hundemer, M.
Singer, R.
Hund, E.
Beimler, J.
Zeier, M.
Kristen, A.
Dengler, T.
Ho, A.
Goldschmidt, H.
机构：
[1] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany
[2] Univ Klinikum Heidelberg, Chirurg Klin, Heidelberg, Germany
[3] Univ Klinikum Heidelberg, Neurol Klin, Heidelberg, Germany
[4] Univ Klinikum Heidelberg, Nierenzentrum, Heidelberg, Germany
[5] Univ Klinikum Heidelberg, Med Klin 3, Heidelberg, Germany
来源：
MEDIZINISCHE KLINIK | 2006年 / 101卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：864 / 865
页数：2
相关论文
共 50 条
  • [1] HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL AMYLOIDOSIS PATIENTS
    Michael, M.
    Kastritis, E.
    Delimbassi, S.
    Kyrtsonis, M. C.
    Papadimetriou, C.
    Apostolides, I.
    Panayiotidis, P.
    Harhalakis, N.
    Pangalis, G.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 469 - 470
  • [2] High-dose melphalan chemotherapy with autologous stem cell transplantation in 44 patients with AL amyloidosis: a single-centre experience
    Schonland, S
    Perz, J
    Hundemer, M
    Bochtler, T
    Hegenbart, U
    Singer, R
    Hund, E
    Beimler, J
    Zeier, M
    Kristen, A
    Dengler, T
    Linke, R
    Ho, A
    Goldschmidt, H
    BONE MARROW TRANSPLANTATION, 2005, 35 : S50 - S50
  • [3] High dose melphalan chemotherapy with autologous stem-cell transplantation in 63 patients with AL-amyloidose: Experience of a centre
    Schronland, S
    Hegenbart, U
    Dengler, J
    Bochtler, T
    Hundenier, M
    Singer, R
    Hund, E
    Beimler, J
    Zeier, M
    Kristen, A
    Dengler, T
    Ho, A
    Gold-schmidt, H
    MEDIZINISCHE KLINIK, 2006, 101 (04) : A45 - A45
  • [4] High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    ACTA HAEMATOLOGICA, 2020, 143 (04) : 381 - 387
  • [5] High-dose melphalan followed by autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis
    Knop, S
    Lengerke, C
    Hebart, H
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S165 - S165
  • [6] High-dose melphalan chemotherapy with autologous stem cell transplantation in patients with AL amyloidosis: No increased mortality using induction and mobilization chemotherapy.
    Schonland, SO
    Hegenbart, U
    Dengler, JB
    Benner, A
    Hundemer, M
    Bochtler, T
    Ho, AD
    Goldschmidt, H
    BLOOD, 2005, 106 (11) : 464B - 465B
  • [7] High-dose melphalan and stem cell rescue for AL amyloidosis
    Gillmore, JD
    Apperley, JF
    Craddock, C
    Madhoo, S
    Pepys, MB
    Hawkins, PN
    AMYLOID AND AMYLOIDOSIS 1998, 1999, : 102 - 104
  • [8] Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation
    Reich, G
    Held, T
    Siegert, W
    Kampf, D
    Dörken, B
    Maschmeyer, G
    BONE MARROW TRANSPLANTATION, 2001, 27 (03) : 341 - 343
  • [9] Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation
    G Reich
    Th Held
    W Siegert
    D Kampf
    B Dörken
    G Maschmeyer
    Bone Marrow Transplantation, 2001, 27 : 341 - 343
  • [10] High-dose melphalan and autologous stem cell transplantation after VAD chemotherapy for systemic light chain (AL) amyloidosis
    Perz, JB
    Schoenland, S
    Hundemer, M
    Linke, RP
    Ho, AD
    Goldschmidt, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S159 - S159
12345